Abstract
ObjectiveThis study aimed to investigate the burden of the COVID-19 pandemic on tuberculosis (TB) trends, patient demographics, disease types and hospitalisation duration within the Respiratory Medicine Department over three distinct phases: pre-COVID-19, COVID-19 and post-COVID-19.DesignRetrospective analysis using electronic medical records of patients with TB admitted between June 2018 and June 2023 was done to explore the impact of COVID-19 on patients with TB. The study employed a meticulous segmentation into pre-COVID-19, COVID-19 and post-COVID-19 eras.SettingNational Institute of Medical Science Hospital in Jaipur, Rajasthan, India.Primary and secondary outcome measuresPrimary outcome includes patients admitted to the Respiratory Medicine Department of the hospital and secondary outcome involves the duration of hospital stay.ResultsThe study encompassed 1845 subjects across the three eras, revealing a reduction in TB incidence during the post-COVID-19 era compared with the pre-COVID-19 period (p<0.01). Substantial demographic shifts were observed, with 5.2% decline in TB incidence among males in the post-COVID-19 era (n=529) compared with the pre-COVID-19 era (n=606). Despite the decrease, overall TB incidence remained significantly higher in males (n=1460) than females (n=385), with consistently elevated rates in rural (65.8%) as compared with the urban areas (34.2%). Extended hospital stays were noted in the post-COVID-19 era compared with the pre-COVID-19 era (p<0.01).ConclusionThe study underscores the influence of the COVID-19 pandemic on the TB landscape and hospitalisation dynamics. Notably, patient burden of TB declined during the COVID-19 era, with a decline in the post-COVID-19 era compared with the pre-COVID-19 era. Prolonged hospitalisation in the post-COVID-19 period indicates the need for adaptive healthcare strategies and the formulation of public health policies in a post-pandemic context. These findings contribute to a comprehensive understanding of the evolving TB scenario, emphasising the necessity for tailored healthcare approaches in the aftermath of a global health crisis.
Reference26 articles.
1. The challenges of severe acute respiratory syndrome Coronavirus 2 (SARS-Cov-2) testing in low-middle income countries and possible cost-effective measures in resource-limited settings;Duma;Global Health,2022
2. Programme GT . Global tuberculosis report 2021. World Health Organization; 2021. Available: https://www.who.int/publications/digital/global-tuberculosis-report-2021/covid-19
3. Coronavirus: why men are more vulnerable to COVID-19 than women?;Bwire;SN Compr Clin Med,2020
4. World Health Organization . Newsroom, fact sheets, detail, tuberculosis. 2023. Available: https://www.who.int/news-room/fact-sheets/detail/tuberculosis
5. World Health Organization . Global tuberculosis report 2023. 2023.